Literature DB >> 11136781

Fecal leukocyte stain has diagnostic value for outpatients but not inpatients.

K L Savola1, E J Baron, L S Tompkins, D J Passaro.   

Abstract

The methylene blue stain for fecal leukocytes (FL) is widely used as an adjunct to slower but more accurate tests of diarrheal etiology, such as stool culture (SCx) or toxin assays for Clostridium difficile. Prior studies investigating the utility of FL for predicting SCx and C. difficile toxin assay (CDTA) results did not evaluate the importance of inpatient versus outpatient status. We conducted a study of patients who submitted a stool specimen to the Stanford Hospital Microbiology Laboratory between May 1998 and April 1999. The results for stool specimens that were tested by FL and by a confirmatory test (either SCx or CDTA) were used to determine whether the FL method helped to predict the results of these tests. Of 797 stools that were tested by FL method and at least one confirmatory test, 502 stools were tested by CDTA, and 473 stools were cultured. The FL test was 14% sensitive and 90% specific for C. difficile with a diagnostic threshold of one white blood cell/high-power field (WBC/HPF). The overall likelihood ratio (LR) for a positive CDTA was 1.4 with a 95% confidence interval (CI) of 0. 5 to 3.7 (P = 0.5) and was similar among inpatients and outpatients. In contrast, the presence of >/=1 WBC/HPF was 52% sensitive and 88% specific for the 27 positive SCx results and helped to predict a positive SCx result (LR, 4.2; 95% CI, 2.7 to 6.5; P < 0.001). The sensitivity of >/=1 WBC/HPF was 57%, and its predictive value for SCx was higher among outpatients (outpatient LR, 5.0; 95% CI, 2.9 to 8.6; P < 0.001; inpatient LR, 1.9; 95% CI, 0.3 to 10.8; P = 0.5). Among inpatients, only 4 (1.5%) of the 273 SCx results were positive, and the presence of >/=1 WBC/HPF was insensitive (25%) and did not predict a positive SCx (LR, 1.9; 95% CI, 0.3 to 10.8; P = 0.5). When the data were reanalyzed using a diagnostic threshold of five WBC/HPF for FL, the predictive power of the FL method was similar. Thus, FL was of no value in predicting CDTA positivity, nor was it helpful in predicting SCx results for inpatients. Neither SCx nor the FL method should routinely be performed on samples from inpatients. Among outpatients, presence of FLs should suggest a bacterial diarrhea in clinically compatible cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136781      PMCID: PMC87712          DOI: 10.1128/JCM.39.1.266-269.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Fecal leukocytes in diarrheal illness.

Authors:  J C Harris; H L Dupont; R B Hornick
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

2.  Differential clinical features and stool findings in shigellosis and amoebic dysentery.

Authors:  P Speelman; R McGlaughlin; I Kabir; T Butler
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

3.  A rapid test for infectious and inflammatory enteritis.

Authors:  J R Miller; L J Barrett; K Kotloff; R L Guerrant
Journal:  Arch Intern Med       Date:  1994 Dec 12-26

4.  Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease.

Authors:  W H Yong; A R Mattia; M J Ferraro
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

5.  Occult blood and fecal leukocytes as screening tests in childhood infectious diarrhea: an old problem revisited.

Authors:  L Huicho; D Sanchez; M Contreras; M Paredes; H Murga; L Chinchay; G Guevara
Journal:  Pediatr Infect Dis J       Date:  1993-06       Impact factor: 2.129

Review 6.  Antibiotic-associated diarrhea.

Authors:  J G Bartlett
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

7.  Interpreting a single antistreptolysin O test: a comparison of the "upper limit of normal" and likelihood ratio methods.

Authors:  G C Gray; J P Struewing; K C Hyams; J Escamilla; A K Tupponce; E L Kaplan
Journal:  J Clin Epidemiol       Date:  1993-10       Impact factor: 6.437

8.  A predictive model to identify Clostridium difficile toxin in hospitalized patients with diarrhea.

Authors:  G S Cooper; M M Lederman; R A Salata
Journal:  Am J Gastroenterol       Date:  1996-01       Impact factor: 10.864

9.  Evaluation of a New Latex Agglutination Test for Fecal Lactoferrin in Travelers' Diarrhea.

Authors: 
Journal:  J Travel Med       Date:  1994-06-01       Impact factor: 8.490

10.  Clostridium difficile colitis: an efficient clinical approach to diagnosis.

Authors:  Y C Manabe; J M Vinetz; R D Moore; C Merz; P Charache; J G Bartlett
Journal:  Ann Intern Med       Date:  1995-12-01       Impact factor: 25.391

View more
  9 in total

1.  Performance assessment of the fecal leukocyte test for inpatients.

Authors:  L A Granville; P Cernoch; G A Land; J R Davis
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 2.  Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile.

Authors:  Christopher R Polage; Jay V Solnick; Stuart H Cohen
Journal:  Clin Infect Dis       Date:  2012-06-14       Impact factor: 9.079

3.  Fecal leukocytes in children infected with diarrheagenic Escherichia coli.

Authors:  Erik H Mercado; Theresa J Ochoa; Lucie Ecker; Martin Cabello; David Durand; Francesca Barletta; Margarita Molina; Ana I Gil; Luis Huicho; Claudio F Lanata; Thomas G Cleary
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

4.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Authors:  Andi L Shane; Rajal K Mody; John A Crump; Phillip I Tarr; Theodore S Steiner; Karen Kotloff; Joanne M Langley; Christine Wanke; Cirle Alcantara Warren; Allen C Cheng; Joseph Cantey; Larry K Pickering
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

5.  Is Fecal Leukocyte Test a good predictor of Clostridium difficile associated diarrhea?

Authors:  Savio Reddymasu; Ankur Sheth; Daniel E Banks
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-04-19       Impact factor: 3.944

6.  A prospective cross sectional study of detection of Clostridium difficile toxin in patients with antibiotic associated diarrhoea.

Authors:  Arun Sachu; Kavitha Dinesh; Ismail Siyad; Anil Kumar; Anu Vasudevan; Shamsul Karim
Journal:  Iran J Microbiol       Date:  2018-02

7.  Diagnostic value of the Vesikari Scoring System for predicting the viral or bacterial pathogens in pediatric gastroenteritis.

Authors:  Dong Ho Shim; Dong Yeon Kim; Ky Young Cho
Journal:  Korean J Pediatr       Date:  2016-03-31

8.  The other Campylobacters: Not innocent bystanders in endemic diarrhea and dysentery in children in low-income settings.

Authors:  Ruthly François; Pablo Peñataro Yori; Saba Rouhani; Mery Siguas Salas; Maribel Paredes Olortegui; Dixner Rengifo Trigoso; Nora Pisanic; Rosa Burga; Rina Meza; Graciela Meza Sanchez; Michael J Gregory; Eric R Houpt; James A Platts-Mills; Margaret N Kosek
Journal:  PLoS Negl Trop Dis       Date:  2018-02-07

9.  Fecal leukocyte in the diagnosis of ulcerative colitis.

Authors:  Takeshi Saraya; Tomokazu Suzuki; Hajime Goto
Journal:  Braz J Infect Dis       Date:  2013-11-22       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.